List of works - Verónica González-Calle

A safety profile of medications used to treat Waldenström's macroglobulinemia.

scientific article

Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.

scientific article published on 2 May 2016

Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.

scientific article published on 6 April 2018

Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma.

scientific article published on 20 March 2015

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma

scientific article published on 08 January 2019

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

scientific article published on 17 June 2019

Improving the conditioning regimen in multiple myeloma

scientific article published on 22 March 2019

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

scientific article published on 16 October 2020

MYC dysregulation in the progression of multiple myeloma

scientific article published on 22 August 2019

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

scientific article published on 06 February 2020

Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients

scientific article published on 12 June 2018

Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case

scientific article published on 11 October 2016

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial

scientific article published on 03 December 2020

Precision Medicine in Myeloma: Challenges in Defining an Actionable Approach.

scientific article published on 23 June 2017

Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma

scientific article

Smoldering Multiple Myeloma: Who and When to Treat.

scientific article

Timing of treatment of smoldering myeloma: early treatment

scientific article published on 01 November 2018

Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study

scientific article published on 04 May 2018

[Primary amyloidosis]

scientific article published on 13 April 2016

List of works by Verónica González-Calle

A safety profile of medications used to treat Waldenström's macroglobulinemia.

Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.

Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.

Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma.

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

Improving the conditioning regimen in multiple myeloma

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

MYC dysregulation in the progression of multiple myeloma

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients

Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial

Precision Medicine in Myeloma: Challenges in Defining an Actionable Approach.

Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma

Smoldering Multiple Myeloma: Who and When to Treat.

Timing of treatment of smoldering myeloma: early treatment

Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study

[Primary amyloidosis]

[Towards precision medicine in myeloma: new evidence and challenges]